@@ Click here For Free Trail
X
Introduce Yourself
I wish to receive Newsletter, Promotional SMS and Special Information
The above information provided by you kept strictly confidential and is not used for any other purpose than sending you trading calls. "We don't SPAM you".
Passion
  •  
Support : +91 90525 24345
Call : +91 77948 69869
Whatsapp : +91 98489 69869
  • NSE
  • BSE
stock alerts / Biocon in focus after biosimilar Trastuzumab gets approval in the EU
Biocon in focus after biosimilar Trastuzumab gets approval in the EU
Dec 19 2018
Indian Intraday Stock Market Shares of Biocon will be watched. Ogivri, a biosimilar Trastuzumab jointly developed by Biocon and Mylan, has been approved in the European Union (EU). The announcement was made before market hours today, 19 December 2018.
 
The European Commission has granted Marketing Authorization for Ogivri to Mylan. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) previously issued a positive opinion recommending approval of Ogivri as a biosimilar to Roche's Herceptin (Trastuzumab) on 18 October 2018. Ogivri is indicated for the treatment of patients with HER2 positive early breast cancer (EBC), metastatic breast cancer (MBC) and metastatic gastric cancer (MGC). Under supervision of the relevant healthcare professional it can be prescribed as either monotherapy or in combination with other medicines dependent on the relevant diagnosis.
 
J. Kumar Infraprojects said it is in receipt of letter of acceptance from National Highways Authority in the name of J.Kumar — J.M. Mhatre (JV) in which J.Kumar is the lead partner for construction of Dwarka Expressway from Shiv Murti Intersection at Km.20 of NH-8 till Rail Under Bridge (RUB) near Dwarka Sector - 21, from Km 0.800 to Km 5.300 package — l in Delhi on EPC mode amounting to Rs 1349 crore. The announcement was made after market hours yesterday, 18 December 2018.
 
NTPC announced that unit 6 of 500 MW capacity of Feroze Gandhi Unchahar Thermal Power Station has been synchronized with grid after boiler restoration. The announcement was made after market hours yesterday, 18 December 2018.
 
IDFC Bank and Capital First announced the completion of merger following the receipt of all requisite shareholder and regulatory approvals and the merged entity will be called IDFC First Bank, subject to shareholders' approval. The announcement was made after market hours yesterday, 18 December 2018.
 
Following the merger, the board of IDFC Bank approved the appointment of Mr. V. Vaidyanathan, founder and chairman of Capital First, as managing director and chief executive officer of the merged entity, subject to shareholders' approval. On a combined basis, IDFC First Bank has on-book loan assets of Rs. 1,02,683 crore, as per the last reported financial results for the quarter ended 30 September 2018. The retail loan book will now contribute 32.46% to the overall loan book. The merger was announced on 13 January 2018, and as per the terms of the merger agreement shareholders will receive 139 shares of IDFC Bank for 10 shares held in Capital First. The board has fixed 31 December 2018 as the record date for determining the shareholders of Capital First who shall be entitled to receive shares of IDFC Bank, as consideration pursuant to the scheme.
 
Karnataka Bank as part of digital initiative has announced its strategic partnership with Paisabazaar.com, one of the India's largest online platforms for financial products to offer the bank's home loan product to customers. Through this partnership, consumers will now be able to choose and apply for a home loan from Karnataka Bank, directly through the Paisabazaar platform. The announcement was made after market hours yesterday, 18 December 2018.
 
Mahindra & Mahindra Financial Services said its board will meet on 21 December 2018 to consider issuing non-convertible debentures with a shelf limit of Rs 10,000 crore. The announcement was made after market hours yesterday, 18 December 2018.
 
Yes Bank said it sold 1.23 crore equity shares of face value Rs 10 each, constituting 2.1279% of the paid-up share capital of Fortis Healthcare ('FHL'), in various tranches last being on 18 December 2018, resulting into a change in holding of the bank by more than 2% of the total shareholding of FHL, from the last disclosure made by the bank on 15 March 2018. The announcement was made after market hours yesterday, 18 December 2018.
 
PVR said its board will meet on 21 December 2018 to consider raising funds. The announcement was made after market hours yesterday, 18 December 2018.
 
Lemon Tree Hotels said it signed a license agreement for a 69 room property located at Viman Nagar, Pune, Maharashtra under the company's brand 'Lemon Tree Hotel'. The hotel is expected to be operational by March 2019 and shall be 3rd hotel besides other 2 owned hotels of the company in Pune. Carnation Hotels, the hotel management arm of the company will be operating and marketing this hotel. The announcement was made after market hours yesterday, 18 December 2018